During the past decade, Centre Etienne Dolet conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Etienne Dolet" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 6 trials, followed by "Pfizer" with 2 trials sponsored, "Centre Oscar Lambret" with 1 trials sponsored, "Nantes University Hospital" with 1 trials sponsored and "National Cancer Institute, France" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Etienne Dolet" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator, "Keyrus Biopharma" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "University Hospital, Caen" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centre Etienne Dolet" are "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Mesothelioma" (2 trials), "ALK Gene Mutation" (1 trials) and "BRAF Gene Mutation" (1 trials). Many other conditions were trialed in "Centre Etienne Dolet" in a lesser frequency.

Most popular intervention types in "Centre Etienne Dolet" are "Drug" (8 trials), "Other" (2 trials), "Radiation" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Chemotherapy" (1 trials), "Chemotherapy with platine" (1 trials), "Chemotherapy without Cisplatine" (1 trials), "ERBITUX" (1 trials) and "Experimental Treatment (PCDE or PE + bevacizumab)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Etienne Dolet" are 9 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Etienne Dolet". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Centre Etienne Dolet, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Etienne Dolet, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".